Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
about
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse eventsRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse eventsRegular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsCombination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and childrenAddition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and childrenRegular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse eventsRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsRegular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse eventsRegular treatment with salmeterol for chronic asthma: serious adverse eventsCombination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and childrenTolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.Tiotropium in asthma: what is the evidence and how does it fit in?Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterolOvercoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trialsPharmacogenomics of long-acting β2-agonists.Effects of asthma treatment: the present and future.Emerging role of long acting muscarinic antagonists for asthmaCombination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells.
P2860
Q24199079-CB16DA08-682F-400A-9537-ABC48207F7D6Q24200353-A1BC1554-6C43-409B-8624-B07ABE5DB2A1Q24201048-C29D5F82-1A4C-460E-ACB4-EC64C2E087B8Q24202005-14C9C7AE-F39B-4CCB-8C73-2ED07E2C407AQ24234581-64B9B6DB-2193-4F1F-93AB-D75C190133C6Q24235303-A775D3DC-0A3C-4173-ABFB-943441450C99Q24240282-DFF50B67-05B8-42C5-8942-7F6D35188A0CQ24241250-CDD9BC80-EBA3-47B6-B992-53F320B5629EQ24241453-C9087E13-0EAE-4E39-8AB9-89804AFD06CFQ24241740-A75068CB-01E4-409A-BD65-0A7C6D8A59F0Q24241960-6208A57C-129D-4116-9C00-CA2895D409CAQ24242173-4BF2B3F6-5475-456F-B86B-EC86D2F176DBQ24816932-2E30B36F-DE3D-4077-80BC-876EA6073DA0Q28067912-2A38C6EE-C90F-4BE3-9DDE-6BCBD2D05E4AQ35536841-E565EB17-0E5E-40E7-B165-D56CDCA42996Q35677555-1BEA73BF-A521-45F0-BFCA-379BD377D5DBQ35734012-F047C4C6-4324-4702-8E55-8BA03B5C731FQ37755242-18C71495-CAF3-4AC6-97B2-C4F7D714412AQ38093655-62BC8CB7-C98A-449C-8BCD-9AABC016CAC1Q45420656-30858AA3-0F1D-477B-BAA8-7068955FB18E
P2860
Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Comparison of combination inha ...... in moderate persistent asthma.
@ast
Comparison of combination inha ...... in moderate persistent asthma.
@en
type
label
Comparison of combination inha ...... in moderate persistent asthma.
@ast
Comparison of combination inha ...... in moderate persistent asthma.
@en
prefLabel
Comparison of combination inha ...... in moderate persistent asthma.
@ast
Comparison of combination inha ...... in moderate persistent asthma.
@en
P2093
P2860
P1476
Comparison of combination inha ...... in moderate persistent asthma
@en
P2093
Brian J Lipworth
Catherine M Jackson
Daniel K C Lee
Wendy J Cockburn
P2860
P304
P356
10.1046/J.1365-2125.2003.01887.X
P407
P50
P577
2003-11-01T00:00:00Z